BASEL, Feb 1 (Reuters) - The chief executive of Novartis said he aims to make the Swiss drugmaker the most
valued pharmaceuticals company.
Speaking at a media briefing after the release of 2022
results on Wednesday, CEO Vas Narasimhan said the ambition was
"also in terms of market value but also in terms of trust".
(Reporting by Ludwig Burger
Editing by Paul Carrel)
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.